Use of Sotorasib in Patients with KRASG12C mutated NSCLC


Drs Socinski and Sabari comment on the use of sotorasib in patients with KRASG12C-mutated NSCLC with brain metastases and review data from the CodeBreak 100 and CodeBreak 200 trials.

Related Videos
Jamie Koprivnikar, MD, and Hana Safah, MD, experts on MDS
Related Content